Treatment of pseudobulbar affect in ALS

Lancet Neurology

Volumn 4, Issue 5, 2005, Pages 270-

  Smith, Richard A ^a   Brooks, Ben R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROMETHORPHAN; MUSCLE RELAXANT AGENT; NEURODEX; QUINIDINE; RILUZOLE; SEROTONIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIZZINESS; EMOTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PSEUDOBULBAR PALSY; QUALITY OF LIFE; SHORT SURVEY; SIDE EFFECT;

EID: 17444428884     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)70058-2     Document Type: Letter

References (7)

1. V Meininger Treatment of emotional lability in ALS Lancet Neurol 4 2005 70
2. BR Brooks, RA Thisted, SH Appel Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine Neurology 63 2004 1363 1370
3. M Klein, JM Musacchio High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents J Pharmacol Exp Ther 251 1989 207 215
4. J Parvizi, SW Anderson, CO Martin, H Damasio, AR Damasio Pathological laughter and crying/a link to the cerebellum Brain 124 2001 1708 1719
5. WM Landau Spasticity: the fable of a neurological demon and the emperor's new therapy Arch Neurol 31 1974 217 219
6. RA Smith, E Gillie, J Licht Palliative treatment of motor neuron disease, Chapter 26 JMBV de Jong Handbook of Clinical Neurology, vol 15: Diseases of the Motor System 1991 Elsevier Amsterdam
7. BJ Turner, EC Lopes, SS Cheema The serotonin precursor 5-hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis Amyotrophic Lateral Scler Other Motor Neuron Disord 4 2003 171 176